Sprites
Sonntag, 26.05.2013Börsentäglich über 11.000 News von 441 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

CELL THERAPEUTICS INC

WKN: A1J2YU  ISIN: US1509348835  Ticker-Symbol: CEPR 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CELL THERAPEUTICS INC Chart 1 Jahr
1-Woche-Intraday-Chart
CELL THERAPEUTICS INC 1-Woche-Intraday-Chart
Aktuelle News zur CELL THERAPEUTICS Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
22.05.10
22.05.5
22.05.20
15.05.98
SEATTLE, May 15, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the following upcoming investor conferences....
Mehr lesen zu:
Cell Therapeutics to Present at Upcoming Investor Conferences
02.05.30
02.05.5
02.05.62
SEATTLE, May 2, 2013 /PRNewswire/ -- Cell Therapeutics, Inc.(CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2013. "In the first quarter, we generated...
Mehr lesen zu:
Cell Therapeutics Reports First Quarter 2013 Financial Results
24.04.107
SEATTLE, April 24, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter financial results on Thursday, May...
Mehr lesen zu:
Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
18.04.22
05.04.241
LONDON, April 5, 2013 /PRNewswire/ -- Swiss pharmaceutical major Novartis AG recently lost a patent case related to its cancer drug in India. The development once again highlights that drug manufacturers...
Mehr lesen zu:
Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics
29.03.13
28.03.5
28.03.5
28.03.4
28.03.2
28.03.88
WASHINGTON (dpa-AFX) - Cell Therapeutics, Inc. (CTIC) Thursday announced a loan agreement with Hercules Technology Growth Capital, Inc. or HTGC, providing for a senior secured term loan...
Mehr lesen zu:
Cell Therapeutics Inks $15 Mln Loan Agreement With Hercules Technology
28.03.65
SEATTLE, March 28, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE:...
Mehr lesen zu:
Cell Therapeutics Secures $15 Million Loan Financing Agreement
25.03.24
14.03.104
NEW YORK, NY -- (Marketwire) -- 03/14/13 -- Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry....
Mehr lesen zu:
Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation / Five Star Equities Provides Stock Research on Cell Therapeutics and Santarus
11.03.129
SEATTLE, March 11, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the ROTH Capital Partners 25th Annual Growth Stock Conference...
Mehr lesen zu:
Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
Seite: 1 2 3 4 5 ... Weiter >>
104 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
CELL THERAPEUTICS INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
MEDIGENE0,93+4,61 %Medigene: Rating wird erneuert
AGENNIX0,07-27,08 %Agennix AG gibt Liquidation bekannt
EVOTEC2,75-0,58 %Evotec-Aktie: Jetzt einsteigen!
ANTISOMA0,0170 %Antisoma PLC: TR1 Notification of major interest in shares
GERON0,851-0,35 %GERON CORP - 8-K, Current Report
Lade...
Aufklappen
Schliessen